Wedbush Securities Inc Pacira Bio Sciences, Inc. Transaction History

Wedbush Securities Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$51.49 - $81.64 $144,480 - $229,081	-2,806 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$60.03 - $76.49 $168,444 - $214,630	2,806 New	2,806 $214,000
Q2 2018 Aug 03, 2018	SELL	$27.5 - $39.8 $276,870 - $400,706	-10,068 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$29.98 - $46.35 $301,838 - $466,651	10,068 New	10,068 $314,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $946M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.